title: Adult respiratory distress syndrome complicating intravenous infusion of low-molecular weight dextran.
abstract: Respiratory failure is one of the most uncommon and serious adverse drug reactions. Low-molecular-weight-dextran (Dextran-40) is a useful adjunctive anti-platelet agent in the setting of coronary angioplasty and intracoronary stent placement. We report the occurrence of the adult respiratory distress syndrome following intravenous infusion of Dextran-40.
authors.affiliation: Department of Cardiology, Deborah Heart and Lung Center, Browns Mills, NJ 08015.
authors.forename: M A
authors.initials: MA
authors.lastname: Taylor
authors.forename: S L
authors.initials: SL
authors.lastname: DiBlasi
authors.forename: R M
authors.initials: RM
authors.lastname: Bender
authors.forename: E C
authors.initials: EC
authors.lastname: Santoian
authors.forename: S D
authors.initials: SD
authors.lastname: Cha
authors.forename: C A
authors.initials: CA
authors.lastname: Dennis
mesh_terms: D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D003324:Coronary Artery Disease / Q000628:therapy; D003911:Dextrans / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D011654:Pulmonary Edema / Q000139:chemically induced*; D012128:Respiratory Distress Syndrome / Q000139:chemically induced*
chemical_list: D003911:Dextrans